Effectiveness of selective muscle-release surgery for children with cerebral palsy: longitudinal and stratified analysis

被引:18
作者
Kondo, I
Hosokawa, K
Iwata, M
Oda, A
Nomura, T
Ikeda, K
Asagai, Y
Kohzaki, T
Nishimura, H
机构
[1] Hirosaki Univ Hosp, Rehabil Ctr, Hirosaki, Aomori 0368563, Japan
[2] Hirosaki Univ Hosp, Sch Hlth Sci, Dept Phys Therapy, Hirosaki, Aomori 0368563, Japan
[3] Koshi Rehabil Hosp, Toyama, Japan
[4] Shinano Handicapped Childrens Hosp, Shimosuwachou, Japan
[5] Tochigi Rehabil Ctr, Dept Orthopaed Surg, Utsunomiya, Japan
[6] Hosp & Home Handicapped Children, Kanazawa, Ishikawa, Japan
关键词
D O I
10.1017/S0012162204000908
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this study was to determine the effectiveness of muscle-release surgery for children with cerebral palsy (CP) using longitudinal and stratified analysis. Twenty-five children with CP (15 females, 10 males; age range 4 to 16 years; mean age 8 years 2 months, SD 3 years 2 months) were selected from five treatment centres in Japan. Twenty-two children had spastic diplegia, two had spastic quadriplegia, and one had athetospastic quadriplegia. Motor function for each child was assessed using the Gross Motor Function Measure (GMFM). Assessment was conducted on eight separate occasions: 1 month and 1 week before surgery, and 1, 2, 4, 6, 9, and 12 months after surgery. Participants' motor function before surgery was classified using the Gross Motor Function Classification System (GMFCS). Six children were classified at level I, three at level II, six at level III, and 10 at level IV. A significant difference was found after surgery in the GMFCS levels III and IV groups (P < 0.05). Improvement in GMFM scores between 1 week before surgery and 12 months after surgery were 1, 5, 8.5, and 8.5 for GMFCS levels I to IV respectively. Results indicate that this treatment is advantageous for improving motor function in children within GMFCS levels III and IV.
引用
收藏
页码:540 / 547
页数:8
相关论文
共 14 条
[1]  
Abel MF, 1999, J PEDIATR ORTHOPED, V19, P366
[2]   Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy [J].
Butler, C ;
Campbell, S .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2000, 42 (09) :634-645
[3]  
Drouin LM, 1996, DEV MED CHILD NEUROL, V38, P1007
[4]   Evaluation of botulinum toxin A therapy in children with adductor spasm by gross motor function measure [J].
Mall, V ;
Heinen, F ;
Kirschner, J ;
Linder, M ;
Stein, S ;
Michaelis, U ;
Bernius, P ;
Lane, M ;
Korinthenberg, R .
JOURNAL OF CHILD NEUROLOGY, 2000, 15 (04) :214-217
[5]  
Matsuo T., 2002, Cerebral palsy: Spasticity-control and orthopaedics: An introduction to orthopaedic selective spasticity-control surgery (OSSCS)
[6]   Selective dorsal rhizotomy: meta-analysis of three randomized controlled trials [J].
McLaughlin, J ;
Bjornson, K ;
Temkin, N ;
Steinbok, P ;
Wright, V ;
Reiner, A ;
Roberts, T ;
Drake, J ;
O'Donnell, M ;
Rosenbaum, P ;
Barber, T ;
Ferrel, A .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2002, 44 (01) :17-25
[7]  
McLaughlin JF, 1998, DEV MED CHILD NEUROL, V40, P220
[8]   Development and reliability of a system to classify gross motor function in children with cerebral palsy [J].
Palisano, R ;
Rosenbaum, P ;
Walter, S ;
Russell, D ;
Wood, E ;
Galuppi, B .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 1997, 39 (04) :214-223
[9]  
Reddihough DS, 2002, DEV MED CHILD NEUROL, V44, P820
[10]   Prognosis or gross motor function in cerebral palsy - Creation of motor development curves [J].
Rosenbaum, PL ;
Walter, SD ;
Hanna, SE ;
Palisano, RJ ;
Russell, DJ ;
Raina, P ;
Wood, E ;
Bartlett, DJ ;
Galuppi, BE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (11) :1357-1363